Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma.
Samantha WebkingMaria L SandovalMichael D ChuongAntonio UcarSantiago AparoFernando De ZarragaIbrahim SahinTiago BiachiDae W KimSarah E HoffeJessica M FrakesRussell F PalmPublished in: Cancer control : journal of the Moffitt Cancer Center (2023)
There was minimal morbidity of local disease progression after SMART in this cohort of oligometastatic PDAC. As systemic therapy options improve, additional strategies to identify patients who may derive benefits from local consolidation or metastasis-directed therapy are needed.